Publication | Closed Access

Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells

Medicinal ChemistryOcular DiseaseOphthalmologyMedicineCytotoxic ProfileDifferent Ocular CellsPharmacotherapyOcular PathologyAqueous HumourOcular PharmacologyPharmacologyComparative AntiproliferativeDrug Discovery